07.10.2015
- International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the...
24.07.2013
- A U.S. Supreme Court ruling giving regulators the right to sue drugmakers for agreements that delay sale of cheaper generic pharmaceuticals should deter some of the most egregious...
23.03.2013
- The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...
05.10.2012
- The Federal Trade Commission asked the US Supreme Court on Thursday to take up its fight against deals between brand-name drug companies and generic firms which they say delay the...
02.10.2012
- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer and a division of Teva Pharmaceuticals to end patent litigation over the...
08.03.2011
- The U.S. Supreme Court let stand a ruling that drug companies can pay rivals to delay production of generic drugs without violating federal antitrust laws. The justices refused to...
02.03.2011
- Teva Pharmaceutical Industries, the world's largest generics drugmaker, said it stands to benefit from the Obama administration's healthcare reform and other plans aimed at getting...
